Gene Therapy for Chinese Hemophilia A — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Gene Therapy for Chinese Hemophilia A — Stella

Recruiting

Back to Hemophilia A trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

Chinese Academy of Medical Science and Blood Disease Hospital, Tianjin, Tianjin Municipality

Key details

Sponsor

Institute of Hematology & Blood Diseases Hospital, China

Enrollment target

~12 participants

Started

March 2021

Primary completion

July 2028

Age range

18 Years and older

Sex

Male only

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov